Search results
Results from the WOW.Com Content Network
Platelets are held within these internal membranes within the cytoplasm of megakaryocytes. There are two proposed mechanisms for platelet release. In one scenario, these proto-platelet processes break up explosively to become platelets. [7] It is possible to visualize the spontaneous release of platelets using holotomographic live-cell imaging ...
Megakaryocytes are precursor cells that are highly specialized. Megakaryocytes give rise to 1,000 to 3,000 platelets. Megakaryocytes function in the process of Thrombopoiesis by producing platelets and releasing platelets into the bloodstream. [6] Megakaryocyte development is regulated mainly by thrombopoietin.
Platelets have no cell nucleus; they are fragments of cytoplasm derived from the megakaryocytes [2] of the bone marrow or lung, [3] which then enter the circulation. Platelets are found only in mammals, whereas in other vertebrates (e.g. birds, amphibians), thrombocytes circulate as intact mononuclear cells. [4]: 3
Thrombopoietin is a glycoprotein hormone produced by the liver and kidney which regulates the production of platelets. It stimulates the production and differentiation of megakaryocytes, the bone marrow cells that bud off large numbers of platelets. [5] Megakaryocytopoiesis is the cellular development process that leads to platelet production.
The promegakaryocytes continue the process of endomitosis, which results in the formation of granular megakaryocytes as the nucleus forms lobes with increased volumes. The megakaryocytes release the platelets into the blood stream. [8] The process of platelet production, beginning with the formation of megakaryoblasts, takes about 7 days.
They circulate in the blood of mammals and are involved in hemostasis, leading to the formation of blood clots. Platelets release thread-like fibers to form these clots. The normal range (99% of population analyzed) for platelets is 150,000 to 450,000 per cubic millimeter. [6] If the number of platelets is too low, excessive bleeding can occur.
The GM-CSF and IL-3 both work together to stimulate production of all lines. When erythropoietin (EPO) is present, red blood cell production from the CFU-GEMM will be activated. G-CSF, M-CSF, IL-5, IL-4, and IL-3 stimulate the production of neutrophils, monocytes, eosinophils, basophils, and platelets, respectively. [4]
Factor V is produced by megakaryocytes, which produce platelets and platelet-derived factor V, and hepatocytes, which produce plasma-derived factor V. [9] The molecule circulates in plasma as a single-chain molecule with a plasma half-life of 12–36 hours. [10] Factor V is able to bind to activated platelets and is activated by thrombin.